No Data
No Data
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...
CollPlant Biotechnologies (NASDAQ:CLGN) Is In A Strong Position To Grow Its Business
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2023 Earnings Call Transcript
CollPlant Biotechnologies Ltd (CLGN) Q4 2023 Earnings Call Transcript Highlights: A Year of ...
Buy Rating Affirmed for Collplant Holdings on Strong Financials and Promising Product Pipeline Advancements
Earnings Call Summary | Collplant(CLGN.US) Q4 2023 Earnings Conference
The following is a summary of the CollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call Transcript:Financial Performance:CollPlant reported Q4 2023 revenues of $299,000, an increase from $58,000